KNOXVILLE, Tenn. — A clinical research company based in Knoxville is playing a key role in the testing of potential vaccines for COVID-19.
Volunteer Research Group is recruiting people in East Tennessee to take part in clinical trials for five different potential vaccines.
Dr. Bill Smith says thousands of volunteers are needed for the studies from now until the end of the year. Anyone 18 and older is eligible.
A drug given to President Donald Trump to treat COVID-19 may end up preventing the virus in others who are exposed.
It's called Regeneron Cov-2 Antibodies, and the company is asking the FDA for emergency authorization.
As of Oct. 8, a clinical trial is underway at Volunteer Research Group in Knoxville on the drug.
Dr. Bill Smith says they are looking for people willing to take part in the study -- specifically people who live with someone who is newly diagnosed with COVID-19.
You can sign up here or call 865-305-3784.